Company Profile
Bastion Therapeutics Limited
11597069•Private Limited With Share Capital
Get Full Access
01/10/2018
7 years
3
—
72110
not scored
Company Overview
Registration, classification & business activity
Bastion Therapeutics Limited (11597069) is a private limited with share capital incorporated on 01/10/2018 (7 years old) and registered in london, N31XW. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Bastion therapeutics is a preclinical stage biotechnology company with a mission to develop novel treg therapies to address the unmet clinical need for inflammatory disorders. we leverage our proprietary grit platform technology to enhance tregs to modulate the immune system and overcome challenges ...
Financial Overview
£0
£0
£0
£0
Key Metrics
3
Directors
43
Shareholders
2
Patents
Board of Directors
Innovate Grants
This company received a grant of £324829.4 for 'Degen-Lock' - A Novel Way Of Protecting The Nervous System In Motor Neurone Disease. The project started on 01/04/2020 and ended on 30/09/2021.
This company received a grant of £56919.0 for In-House Cell Therapy Production During Covid19 Pandemic. The project started on 01/06/2020 and ended on 31/03/2021.
Import / Export
Risk Assessment
not scored
International Score
Future Factor
excellent
Performance Rating